chr18-36187516-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_017947.4(MOCOS):c.-24G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.685 in 1,230,294 control chromosomes in the GnomAD database, including 291,256 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.63 ( 31537 hom., cov: 34)
Exomes 𝑓: 0.69 ( 259719 hom. )
Consequence
MOCOS
NM_017947.4 5_prime_UTR
NM_017947.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.93
Genes affected
MOCOS (HGNC:18234): (molybdenum cofactor sulfurase) This gene encodes an enzyme that sulfurates the molybdenum cofactor which is required for activation of the xanthine dehydrogenase (XDH) and aldehyde oxidase (AO) enzymes. XDH catalyzes the conversion of hypoxanthine to uric acid via xanthine, as well as the conversion of allopurinol to oxypurinol, and pyrazinamide to 5-hydroxy pyrazinamide. Mutations in this gene cause the metabolic disorder classical xanthinuria type II which is characterized by the loss of XDH/XO and AO enzyme activity, decreased levels of uric acid in the urine, increased levels of xanthine and hypoxanthine in the serum and urine, formation of xanthine stones in the urinary tract, and myositis due to tissue deposition of xanthine. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 18-36187516-G-A is Benign according to our data. Variant chr18-36187516-G-A is described in ClinVar as [Benign]. Clinvar id is 1258652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-36187516-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.851 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MOCOS | NM_017947.4 | c.-24G>A | 5_prime_UTR_variant | 1/15 | ENST00000261326.6 | NP_060417.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MOCOS | ENST00000261326.6 | c.-24G>A | 5_prime_UTR_variant | 1/15 | 1 | NM_017947.4 | ENSP00000261326 | P1 | ||
COSMOC | ENST00000687261.2 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.633 AC: 96161AN: 151946Hom.: 31530 Cov.: 34
GnomAD3 genomes
AF:
AC:
96161
AN:
151946
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.695 AC: 3083AN: 4436Hom.: 1091 AF XY: 0.701 AC XY: 1813AN XY: 2588
GnomAD3 exomes
AF:
AC:
3083
AN:
4436
Hom.:
AF XY:
AC XY:
1813
AN XY:
2588
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.692 AC: 746350AN: 1078236Hom.: 259719 Cov.: 52 AF XY: 0.693 AC XY: 352979AN XY: 509542
GnomAD4 exome
AF:
AC:
746350
AN:
1078236
Hom.:
Cov.:
52
AF XY:
AC XY:
352979
AN XY:
509542
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.633 AC: 96193AN: 152058Hom.: 31537 Cov.: 34 AF XY: 0.638 AC XY: 47445AN XY: 74326
GnomAD4 genome
AF:
AC:
96193
AN:
152058
Hom.:
Cov.:
34
AF XY:
AC XY:
47445
AN XY:
74326
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2790
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at